Aurora Cannabis Inc
Top Developments in the Cannabis Industry’s Early Years
In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.
Supreme Cannabis’ Target Price Changed in December
Supreme Cannabis has been one of the worst performers in the cannabis sector year-to-date with a return of -49% as of December 19.
Cronos Group: Analysts’ Target Price and Recommendations
Cronos Group (CRON) has been pretty active in December. The company has delivered a 43% return YTD (year-to-date) as of December 18.
These Cannabis Stocks Were Up in Premarket Trading
On December 19 at 8:40 AM EST, Tilray (TLRY) was trading with a gain of nearly 4.6% at ~$80.
Tilray Makes a Bold Prediction on Cannabis Legalization in the US
Canopy Growth is preparing for the US market, but Tilray (TLRY) is not far behind.
Canadian Cannabis Companies Set Sights on US Hemp Market
One of the most important changes that cannabis companies have been waiting for is legislation on hemp farming.
Farm Bill Clears the Way for Cannabis Companies
On December 11, we reported that the farm bill is expected to be voted on later this week. The farm bill contained a lot of important changes.
It’s Official: Altria Acquires a Stake in Cronos Group
Altria officially announced today that it acquired a ~45% stake in Cronos for $1.8 billion.
Canopy Growth Adds Storz & Bickel to Its Portfolio
On December 6, Canopy Growth (WEED) acquired Storz & Bickel, a German vaporizer company, for nearly 145 million euros.
Eight Capital Cut Aphria’s Target Price
Aphria stock lost nearly 25% on December 5. The stock has lost 42% in the three trading days in December.
Aphria Continued to Fall despite the Company’s Defense
On December 4, Aphria issued a press release defending its acquisitions in Latin America. The company tried to boost investors’ confidence.
One Chart That Shows What Makes Cannabis Attractive to Altria
As the cannabis space has increasingly become crowded, companies such as Cronos Group would greatly benefit from a company such as Altria.
Aurora Advances in Czech Republic with Medical Cannabis Shipments
On November 27, Aurora Cannabis (ACB) (ACBFF) announced that it completed its first shipment to the Czech Republic.
Is New Jersey Closer to Legalizing Recreational Cannabis?
If New Jersey passes the bill to legalize recreational cannabis, it will become the 11th state to legalize recreational cannabis in the United States.
Tilray’s November Price Target and Recommendation Update
Tilray (TLRY), which reported its earnings on November 13, missed both top-line and bottom-line consensus estimates.
Why Canopy Growth’s Losses Widened in the Second Quarter
During the second quarter, Canopy Growth’s (WEED) (CGC) operating losses widened from ~$1 million to almost $214 million.
How Tilray Is Advancing in International Markets
In its earnings call, Tilray (TLRY) stated that its Canadian entity will serve as a production hub to meet global cannabis demand.
Michigan Votes in Favor of Legalizing Recreational Marijuana
On November 7, Michigan voted in favor of legalizing recreational marijuana.
Jeff Sessions’ Resignation Could Be Good News for Cannabis Stocks
On November 7, US Attorney General Jeff Sessions resigned from his position.
ICC Labs’ Shareholders Approve Acquisition by Aurora Cannabis
On November 6, Aurora Cannabis (ACB) (ACBFF) announced that it received approval from shareholders to acquire ICC Labs.
Aurora Cannabis Increases Stake in Choom Holdings
On November 5, Aurora Cannabis (ACB) (ACBFF) increased its stake in Choom Holdings, a cannabis product retailer.
Cannabis Stocks’ EV-to-EBITDA Multiples on October 23
All nine cannabis stocks experienced a decline in the forward EV-to-EBITDA multiple as of October 23—compared to October 9.
Analyzing the Cannabis Sector’s EV-to-EBITDA Multiple
The median EV-to-EBITDA multiple of the nine cannabis stocks as of October 23 stood at 34x, which declined from 44.6x as of October 9.
Cannabis Stocks Slid ahead of Cannabis Legalization in Canada
The Horizons Marijuana Life Sciences ETF (HMMJ) lost almost 4.7% yesterday.
Most Analysts Recommend a ‘Buy’ for Aurora Cannabis
Aurora Cannabis (ACB) (ACBFF) stock rose by 9.9% to its highest level at 15.1 Canadian dollars on October 15.
Tobacco Companies and Their Newfound Interest in Cannabis
On October 10, Reuters reported that tobacco giant Altria is in discussions with Aphria (APHQF) about acquiring a stake in the company.
Canopy Growth Exporting Medical Cannabis for US Research
On October 9, Canopy Growth (CGC) (WEED) announced that it has completed a legal transfer of medical cannabis to the United States.
Aurora Cannabis Applies to Be Listed on New York Stock Exchange
On October 9, Aurora Cannabis announced that it has applied to be listed on the New York Stock Exchange.
More Valuations for the Cannabis Sector in October
The median forward EV-to-EBITDA multiple for our nine cannabis companies on October 8 was 43.2x. That was 30% lower than September.
Aurora Cannabis Moves Closer to Uruguay and Colombia
Aurora Cannabis has moved closer to having a presence in Uruguay and Colombia. The company’s board approved the deal with ICC Labs.
Aphria Announces Developments in South American Markets
On September 27, Aphria (APHQF) announced developments in the South American market with the acquisition of LATAM Holdings.
Canaccord Genuity Raises Aurora Cannabis’s Price Target
On September 25, Canaccord Genuity raised its price target for Aurora Cannabis (ACB)(ACBFF) to 13 Canadian dollars from 11 Canadian dollars.
What’s the Estimated Market for Medical Cannabis in the US?
The annual US market potential for cannabis is estimated at 2.3 million kilograms.
Tilray Sinks 17.6% on September 20—What Happened?
On September 20, Tilray (TLRY) sank 17.6% to $176.40, tapping the brakes after the recent frenzy—at least for now.
EV-to-EBITDA: Another Tool to Navigate the Cannabis Sector
The median EV-to-EBITDA multiple of pure Canadian cannabis companies (MJ) stood at 63.2x, which was significantly higher compared to levels since January 2017.
Take a Look at Valuations before Jumping into Cannabis Stocks
Cannabis stocks have soared in recent weeks in anticipation of October 17, the date when recreational cannabis sales are slated to begin in Canada.
Tilray Soars ~60% on September 19—What Drove the Stock Up?
Cannabis stock Tilray (TLRY) soared to a new high of $253.80, up ~60% on September 19. TLRY has risen ~1,390% above its IPO price of $17.00.
Aurora Cannabis Comments on Coca-Cola Development
Today, Aurora Cannabis (ACB) noted that while it doesn’t have a confirmed deal with Coca-Cola, it doesn’t reject the Coca-Cola development.
Why Tilray Cannabis Stock Popped Today
On September 18, cannabis stock Tilray (TLRY) popped about 27% to an all-time high of $153.8 in the mid-day session.
Coca-Cola to Quench Market Thirst with Cannabis-Infused Beverages
Soda giant the Coca-Cola Company (KO) is now looking for growth opportunities in the legal marijuana market.
A Look at Aphria’s Price Target in September
The overall consensus recommendation for Aphria is a “buy.”
Here’s the Consensus Target for Aurora Cannabis in September
On September 10, PI Financial raised its price target on Aurora Cannabis from 13 Canadian dollars to 15 Canadian dollars.
Analysts Raise Price Target for Canopy Growth in September
Canopy Growth is one of the top cannabis stocks (MJ) in terms of market capitalization followed by Aurora Cannabis (ACB) (ACBFF) and Aphria (APHQF).
International Cannabis Market Is Already Firing Up
The third major market segment for cannabis companies is legal medicinal cannabis outside Canada.
How Cannabis Companies Are Blanketing the Cannabis Market
Product differentiation appears to be the primary strategic direction for most cannabis players to blanket the market with several products.
Why Cannabis Stocks Are on the Rise
The reason cannabis stocks are rising could be because October 17 is approaching.
Scotts Miracle-Gro Explores Opportunities in Cannabis Market
SMG’s partnership with the Flowr Corporation could give it an opportunity to pursue options to enter the cannabis cultivation business.
Sifting through the Big List of Cannabis Stocks to Find a Winner
The cannabis bulls are back in the market with cannabis stocks seeing meaningful gains every day.
Canopy Growth Receives Target Price Upgrades
Cormark Securities raised its target price for Canopy Growth to 40 Canadian dollars from 33 Canadian dollars, which represents an increase of almost 21%.
Canopy Growth Reported Its Q1 2019 Results on August 14
Canopy Growth reported its earnings for the first quarter of 2019 on August 14. The company is one of the largest cannabis producers by capacity.
Analysts Remain Optimistic about Aurora Cannabis
Aurora Cannabis stock (ACB) (ACBFF) has had a terrible performance over the last month.
Will Scotts Miracle-Gro’s Q3 Earnings Be Another Disappointment?
The Scotts Miracle-Gro Company (SMG) is set to announce its third-quarter earnings on July 31 after the market closes.
How Supplier Concentration Can Affect Cannabis Players
Some provinces have opted to keep their supplier bases small.
Aurora Cannabis Announces Partnership with Cosmetic Company
On July 11, Aurora Cannabis announced it had established an agreement with Evio Beauty Group to develop hemp-based and CBD-based cosmetic products.
Aurora Cannabis Moves to Grab Pre-Roll Cannabis Market Segment
Aurora Cannabis announced on July 11 that it entered a joint partnership with Wagner Dimas through a cash and share transaction contingent on milestone achievement.
What EV-to-EBITDA Multiples Say about the Cannabis Sector
The EV-to-EBITDA multiple for the cannabis sector increased slightly to 36.3x as of July 10 from 35.4x a month ago.
Which Cannabis Stocks Are above Peer Median Valuation Multiple?
As of July 10, Canopy Growth (WEED) (CGC) was trading at a forward enterprise-value-to-sales multiple of 23.7x.
When’s the Right Time to Jump into Cannabis Stocks?
As of July 10, the forward enterprise-value-to-sales multiple for the Canadian cannabis sector was 9.3x.
Canopy Growth Moves to Acquire Hiku Brands Company
On July 10, Canopy Growth (WEED) (CGC) announced that it had entered an agreement to acquire Hiku Brands Company (HIKU).
Alberta Announces Recreational Cannabis Suppliers
Out of 31 applications, only 13 won bids to supply cannabis to the province of Alberta.
Digging Deeper into Cannabis Product Strategy
Canopy Growth’s partnership with Constellation Brands to develop cannabis-based beverages appears to be geared at the non-user market through a more casual and acceptable format of consumption.
Cannabis Stocks Took a Nosedive Last Week
Last week, the cannabis sector slipped into negative territory. The Horizons Marijuana Life Sciences ETF (HMMJ) fell about 8.8%.
Top Four Developments We’re Watching in Cannabis Sector: Part 2
Cannabis producers (MJ) have ramped up their production capacities to meet the anticipated demand for cannabis.
Canada’s Cannabis Act C-45 Makes Progress in the Senate
On May 28, Bill C-45, Canada’s recreational cannabis legalization bill, saw further progress in the Senate.
What Investors Are Paying for Cannabis Sector’s Forward EBITDA
The enterprise-value-to-EBITDA multiple for Canadian-licensed producers moved sideways in the last two weeks.
What Investors Are Paying for Cannabis Sector’s Forward Sales
In the week ended May 25, the forward enterprise-value-to-sales multiple for the Canadian cannabis sector declined to 10.4x.
Aurora Cannabis Stock Rises 5.8% on Investment in CTT
On May 22, Aurora Cannabis acquired a 9.1% ownership interest in CTT Pharmaceutical Holdings through a private placement.
MedReleaf Stock Rises on Aurora Cannabis Acquisition
Today, Aurora Cannabis (ACB)(ACBFF) announced that it agreed to acquire all of MedReleaf’s (MEDFF) outstanding common shares for about 3.2 billion Canadian dollars.
TGOD: New IPO in the Cannabis Space Last Week
The cannabis industry has seen a surge in producers seeking to gain a piece of the Canadian recreational cannabis market (MJ).
Ratings and Price Target Updates: WEED, ACB, LEAF
Between April 27 and May 3, Canopy Growth (WEED) stock has risen almost 9% to 29.9 Canadian dollars from its close of 27.3 Canadian dollars last week.
How Aurora Cannabis and MedReleaf Stack Up in Cannabis Sector
Cannabis companies are on an acquisition spree, and companies have made vertical and horizontal acquisitions within the industry.
Comparing Cannabis Producers’ EV-to-Sales Valuation Multiples
Aurora Cannabis (ACB)(ACBFF) was trading at a premium of 14.8x, compared to its median of 7.5x since January 2017.
Ratings and Price Target Changes for Aurora Cannabis in April
Aurora Cannabis (ACB) (ACBFF) has had a disappointing run so far this year, with the stock falling 32% YTD.
Why Hydropothecary Stock Rose 13% Yesterday
On April 11, Hydropothecary (HYYDF) stock surged 13.2% after it became the SAQ’s (Société des alcools du Québec) preferred non-medical cannabis supplier.
A Look at Aurora Cannabis’s Partnerships
Aurora Cannabis has acquired approximately a one-fifth interest in Hempco for a supply of raw materials at low costs for cannabidiol extraction.
National Access Cannabis to Get Cannabis from CannaRoyalty
Last week, National Access Cannabis signed a binding term sheet with CannaRoyalty (CRZ) to carry the latter’s products in its stores across Canada.
Digging Deeper into Canopy Growth’s Cost per Gram
In fiscal 3Q18, which ended in December 2017, the weighted average cost per gram for Canopy Growth stood at 2.53 Canadian dollars.
Comparing Major Cannabis Players’ Prices and Cost Structures
Selling prices and per-gram production costs for cannabis will likely be defining factors in the success of Canadian cannabis producers.
Aurora Cannabis Added to TSX Composite Index
Over the past few months, Aurora Cannabis (ACB) (ACBFF) has become one of the most actively traded stocks on TSX.
Unlike Canopy, Aurora Cannabis Will Build Capacity outside Canada
Aurora Cannabis (ACB) (ACBFF), another licensed cannabis producer, is also doing its part to expand its capacity.
Shoppers Drug Mart Makes Supply Deal with Aurora Cannabis
Last week, Shoppers Drug Mart entered a supply agreement with Aurora Cannabis (ACB)(ACBFF) for medical cannabis.
What Cronos Group’s Listing on the NASDAQ Global Market Means
With the elevation of its listing to the NASDAQ Global Market from the NASDAQ International Designation program, Cronos Group’s (PRMCF) management believes…
Why Cannabis Stock Cronos Group Surged 11% Yesterday
On February 26, cannabis company (HMMJ) Cronos Group (MJN)(PRMCF) surged almost 10.8%.
What Happened in the Cannabis Sector Last Week
Supply agreement with Sunniva With recreational cannabis set to become legal in Canada in mid-2018, Canopy Growth (WEED) continued to make developments to meet the anticipated demand with yet another announcement last week. On February 21, Canopy Growth signed a definitive agreement with Sunniva to purchase up to 90 tons of dried cannabis over two years. The […]
Why Canopy Growth’s BC Cannabis Cultivation License Is a Big Deal
On February 20, 2018, Canopy Growth (WEED) announced that it had received a cultivation license for one of its two sites at Aldergrove, British Columbia, under its BC Tweed Joint Venture.
A Look at 2 New Marijuana ETFs that Debuted Last Week
While marijuana stocks (MJX) ended in the negative territory week-over-week last week, two new marijuana sector-specific ETFs debuted.
Key Developments in the Cannabis Sector Last Week
The week ending February 16 wasn’t so positive for marijuana stocks even though the broader market indexes ended in the positive territory.
How Canopy Growth Is Preparing for Legalized Cannabis
During 3Q18, Canopy Growth increased its inventory and biological assets to a value of 108.3 Canadian dollars from 56 million Canadian dollars in 3Q17.
What Were Canopy Growth’s 3Q18 Sales Drivers?
Sales volume, mix, and selling prices are key drivers for Canopy Growth’s (WEED) sales as well as for companies (HMLSF) such as Aphria (APHQF), Aurora Cannabis (ACBFF), and MedReleaf (MEDFF).
What Analysts Estimate for Cannabis Companies’ Earnings Margins
Let’s now look at how capacity expansion could translate into cannabis companies’ margins.
Aurora Cannabis: Does Investment in Liquor Stores Fit Framework?
With the opportunity for private players to run cannabis stores in British Columbia and Alberta, the partnership of Aurora Cannabis and Liquor Stores NA could come at an opportune time.
Aurora Cannabis Announced Another Investment on February 5
On February 5, 2018, Aurora Cannabis (ACB) (ACBFF) issued a press release that gave details on its latest investment in Liquor Stores NA (LIQ).
Cannabis Stocks Rise while the Market Plummets on February 5
While the market continued its rout, cannabis stocks held up on February 5, 2018. The Horizons Marijuana Life Sciences Index ETF (HMLSF) rose 1.9% that day.
A Review of the Biggest Losers in the Cannabis Sector Last Week
With the increased perception of market risk, it’s natural that cannabis-related stocks also experienced a sell-off last week. Let’s look at this in more detail.
What Scotts Miracle-Gro Said about Its Cannabis-Focused Business
According to Scotts Miracle-Gro, the Hawthorne segment’s sales fell $12 million in 1Q18, excluding acquisitions.
Why Scotts Miracle-Gro Stock Fell 14% on January 30
On Tuesday, January 30, 2018, Scotts Miracle-Gro (SMG) reported its 1Q18 earnings with a GAAP loss per share of $0.35. The stock took a significant beating and fell 14%.
How Aphria’s Global Footprint Could Change after the Nuuvera Acquisition
After the acquisition closes, Aphria’s shareholders will represent 85.2% of the pro forma ownership, while Nuuvera shareholders will represent 14.8%.
Canopy Growth’s Recreational Marijuana Sales Channel
Canopy Growth stated that the Canadian provinces of Ontario and New Brunswick announced that the retail and distribution of recreational marijuana would be overseen by their liquor control boards.
Why the Marijuana Wave May Not Be the Same as Cryptocurrency
In 2018, two investment waves set the market ablaze—marijuana and cryptocurrencies. Although cryptocurrencies have slid since early January, the marijuana wave has held up so far.
Aurora Cannabis Acquires CanniMed Therapeutics
The marijuana space is already heating up with mergers and acquisitions ahead of recreational marijuana legalization expected in Canada later this year.